Episodebeskrivelse
On this episode of Translating Proteomics, co-hosts Parag Mallick and Andreas Huhmer of Nautilus Biotechnology discuss how clinical researchers can leverage proteomics for drug development. Some of the themes covered in this episode include:
· Proteomics and pre-clinical models
· How proteomics can drive patient selection
· Choosing the right end points in clinical trials
Chapters
00:00 – 01:06 – Introduction
01:06 – 06:51 – Proteomics in pre-clinical studies
06:51 – 11:40 – The importance of choosing the right model for preclinical work
11:40 – 17:10 – How proteomics is used in Phase I/II…
Website: nautilus.bio

